News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
872,635 Results
Type
Article (88147)
Company Profile (825)
Press Release (783644)
Multimedia
Podcasts (205)
Webinars (30)
Section
Business (233341)
Career Advice (4151)
Deals (39893)
Drug Delivery (155)
Drug Development (91469)
Employer Resources (205)
FDA (18424)
Job Trends (17437)
News (398093)
Policy (39990)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3023)
Academic (2)
Accelerated approval (38)
Adcomms (36)
Allergies (161)
Alliances (56982)
ALS (188)
Alzheimer's disease (1823)
Antibody-drug conjugate (ADC) (369)
Approvals (18621)
Artificial intelligence (669)
Autoimmune disease (187)
Automation (46)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (211)
Biotechnology (490)
Bladder cancer (170)
Brain cancer (68)
Breast cancer (691)
Cancer (5272)
Cardiovascular disease (467)
Career advice (3576)
Career pathing (42)
CAR-T (317)
CDC (66)
Celiac Disease (2)
Cell therapy (867)
Cervical cancer (39)
Clinical research (77315)
Collaboration (1925)
Company closure (5)
Compensation (1221)
Complete response letters (78)
COVID-19 (3002)
CRISPR (106)
C-suite (949)
Cystic fibrosis (155)
Data (6574)
Decentralized trials (2)
Denatured (75)
Depression (160)
Diabetes (550)
Diagnostics (7300)
Digital health (54)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (325)
Drug pricing (230)
Drug shortages (36)
Duchenne muscular dystrophy (255)
Earnings (100558)
Editorial (69)
Employer branding (25)
Employer resources (174)
Events (135683)
Executive appointments (1066)
FDA (21763)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (12)
Frontotemporal dementia (25)
Funding (1625)
Gene editing (227)
Generative AI (71)
Gene therapy (704)
GLP-1 (1160)
Government (5474)
Grass and pollen (8)
Guidances (389)
Healthcare (20974)
HIV (70)
Huntington's disease (53)
IgA nephropathy (89)
Immunology and inflammation (307)
Immuno-oncology (73)
Indications (126)
Infectious disease (3316)
Inflammatory bowel disease (216)
Inflation Reduction Act (17)
Influenza (131)
Intellectual property (266)
Interviews (817)
IPO (17969)
IRA (61)
Job creations (5202)
Job search strategy (2867)
JPM (72)
Kidney cancer (19)
Labor market (97)
Layoffs (662)
Leadership (43)
Legal (10166)
Liver cancer (100)
Longevity (19)
Lung cancer (709)
Lymphoma (393)
Machine learning (46)
Management (66)
Manufacturing (914)
MASH (180)
Medical device (15082)
Medtech (15146)
Mergers & acquisitions (23022)
Metabolic disorders (1463)
mRNA (200)
Multiple sclerosis (176)
NASH (23)
Neurodegenerative disease (378)
Neuropsychiatric disorders (108)
Neuroscience (3223)
Neurotech (1)
NextGen: Class of 2026 (7710)
Non-profit (5120)
Now hiring (69)
Obesity (715)
Opinion (345)
Ovarian cancer (173)
Pain (223)
Pancreatic cancer (247)
Parkinson's disease (313)
Partnered (39)
Patents (541)
Patient recruitment (537)
Peanut (64)
People (67114)
Pharmaceutical (145)
Pharmacy benefit managers (34)
Phase 1 (23891)
Phase 2 (33552)
Phase 3 (25265)
Pipeline (5813)
Policy (353)
Postmarket research (3554)
Preclinical (10718)
Press Release (72)
Prostate cancer (267)
Psychedelics (60)
Radiopharmaceuticals (316)
Rare diseases (984)
Real estate (7444)
Recruiting (81)
Regulatory (29291)
Reports (69)
Research institute (2740)
Resumes & cover letters (652)
Rett syndrome (28)
RNA editing (21)
RSV (90)
Schizophrenia (165)
Series A (273)
Series B (205)
Service/supplier (30)
Sickle cell disease (109)
Special edition (28)
Spinal muscular atrophy (178)
Sponsored (49)
Startups (4339)
State (2)
Stomach cancer (21)
Supply chain (116)
Tariffs (101)
The Weekly (128)
Vaccines (1186)
Venture capital (101)
Weight loss (490)
Women's health (102)
Worklife (22)
Date
Today (156)
Last 7 days (781)
Last 30 days (2933)
Last 365 days (32866)
2026 (4948)
2025 (33228)
2024 (38141)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1290)
Alabama (95)
Alaska (7)
Arizona (352)
Arkansas (15)
Asia (51666)
Australia (9078)
California (12046)
Canada (3439)
China (1217)
Colorado (507)
Connecticut (524)
Delaware (360)
Europe (118842)
Florida (1784)
Georgia (387)
Hawaii (4)
Idaho (68)
Illinois (1007)
India (78)
Indiana (568)
Iowa (24)
Japan (458)
Kansas (135)
Kentucky (46)
Louisiana (31)
Maine (84)
Maryland (1500)
Massachusetts (8836)
Michigan (375)
Minnesota (680)
Mississippi (6)
Missouri (144)
Montana (36)
Nebraska (29)
Nevada (131)
New Hampshire (88)
New Jersey (3229)
New Mexico (33)
New York (3176)
North Carolina (1665)
North Dakota (10)
Northern California (5819)
Ohio (372)
Oklahoma (23)
Oregon (55)
Pennsylvania (2404)
Puerto Rico (25)
Rhode Island (52)
South America (1665)
South Carolina (70)
South Dakota (1)
Southern California (4658)
Tennessee (184)
Texas (1895)
United States (43360)
Utah (366)
Vermont (1)
Virginia (304)
Washington D.C. (88)
Washington State (1003)
West Virginia (4)
Wisconsin (138)
Wyoming (2)
There are 872,635 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
PolyPid Announces Participation in Upcoming March 2026 Investor Conferences
February 25, 2026
·
1 min read
C-suite
Sarepta CEO Doug Ingram To Step Down as Muscular Dystrophy Mission Hits Home
When Doug Ingram became Sarepta Therapeutics’ CEO in 2017, he didn’t have a connection to muscular dystrophy, but he has developed a fierce passion for the therapeutic area. He will step aside from his role to dedicate more time to his family.
February 25, 2026
·
2 min read
·
Annalee Armstrong
Manufacturing
Novartis Names Texas City as Location of Its 5th US Radiopharmaceutical Facility
The Denton site is part of a network of manufacturing plants Novartis is building across the U.S. to make cancer drugs that must be shipped to patients quickly.
February 25, 2026
·
2 min read
·
Nick Paul Taylor
Weight loss
Novo Leans Into Oral Route With Weight Loss Partnership Worth up to $2.1B
After its next-generation obesity asset CagriSema lost a head-to-head matchup with Eli Lilly’s Zepbound, Novo Nordisk is throwing more money into the obesity space, striking a deal with Vivtex to advance novel weight loss pills.
February 25, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Intelligent Bio Solutions Successfully Manufactures and Ships First Readers with New Partner, Accelerating Scale and Driving Gross Margin Expansion in Anticipation of Planned U.S. Entry
February 25, 2026
·
5 min read
Press Releases
Parker Institute for Cancer Immunotherapy Announces Appointment of Bob Purcell as Chief Communications Officer
February 25, 2026
·
3 min read
Press Releases
Becton, Dickinson and Company Announces Early Tender Results and Upsizing of Offer SubCap and Aggregate Offer Cap
February 25, 2026
·
10 min read
Press Releases
Ultima Genomics and Hamilton Partner to Automate Sample Preparation and Amplification Workflows for the Ultima Family of Sequencing Systems to Enable Improved Lab Operations and Drive Sequencing at Scale
February 25, 2026
·
5 min read
Press Releases
YD Bio Limited Announces Strategic Partnership with YC Biotech Co., Ltd. to Establish a Taiwan-U.S. Dual-Core Regulatory Platform
February 25, 2026
·
5 min read
Press Releases
Curanex Provides Operational Update on Key Regulatory Milestones
February 25, 2026
·
5 min read
1 of 87,264
Next
